Results 71 to 80 of about 5,690,964 (274)
Molecular Oncology, EarlyView.The LEXOVE prospective study evaluated plasma cell‐free extracellular vesicle (cfEV) dynamics using Bradford assay and dynamic light scattering in metastatic non‐small cell lung cancer patients undergoing first‐line treatments, correlating a ∆cfEV < 20% with improved median progression‐free survival in responders versus non‐responders.
Valerio Gristina +17 more
wiley +1 more source
Current Status of Self-transcendence among Lung Cancer Patients and Its Influencing Factors
Chinese Journal of Lung CancerBackground and objective Different degrees of self-transcendence exist in lung cancer patients, which can stimulate patients' self-awareness and promote them to face negative events in life positively, thus improving patients' quality of life and ...
Xue YANG +4 more
doaj +1 more source
3D Neural Network for Lung Cancer Risk Prediction on CT Volumes [PDF]
arXiv, 2020 With an estimated 160,000 deaths in 2018, lung cancer is the most common cause of cancer death in the United States. Lung cancer CT screening has been shown to reduce mortality by up to 40% and is now included in US screening guidelines. Reducing the high error rates in lung cancer screening is imperative because of the high clinical and financial ...
arxiv
Low-Cost Lung Cancer Detection Using Machine Learning on Breath Samples [PDF]
arXiv, 2023 In recent years, electronic nose devices have become a popular approach for identifying respiratory disorders including lung cancer. Traditional e-nose systems have had very consistent principles and patterns of sensor responses. After coming to the realization that detecting cancer at early stages can save 99 percent of lives, it has become imperative
arxiv
Erlotinib in previously treated non-small-cell lung cancer.
New England Journal of Medicine, 2005 BACKGROUND We conducted a randomized, placebo-controlled, double-blind trial to determine whether the epidermal growth factor receptor inhibitor erlotinib prolongs survival in non-small-cell lung cancer after the failure of first-line or second-line ...
F. Shepherd +18 more
semanticscholar +1 more source
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.
New England Journal of Medicine, 2020 BACKGROUND Lung cancer is made up of distinct subtypes, including non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Although overall mortality from lung cancer has been declining in the United States, little is known about mortality ...
N. Howlader +8 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.We quantified and cultured circulating tumor cells (CTCs) of 62 patients with various cancer types and generated CTC‐derived tumoroid models from two salivary gland cancer patients. Cellular liquid biopsy‐derived information enabled molecular genetic assessment of systemic disease heterogeneity and functional testing for therapy selection in both ...
Nataša Stojanović Gužvić +31 more
wiley +1 more source
Frontiers in OncologyAnaplastic lymphoma kinase (ALK) inhibitors have shown efficacy in treating ALK-positive advanced non-small cell lung cancer (NSCLC) patients. However, the effectiveness of ensartinib neoadjuvant therapy remains ambiguous.
Hao Zhang +19 more
doaj +1 more source
Drug Delivery, 2021 Topotecan is potent anti-cancer drug approved for various malignancies but hematopoietic toxicities undermine its wider application and use of its most effective dose. This study aims to improve these limitations through inhalation-delivery.
Philip J. Kuehl +8 more
doaj +1 more source
AI-Decision Support System Interface Using Cancer Related Data for Lung Cancer Prognosis [PDF]
arXiv, 2021 Until the beginning of 2021, lung cancer is known to be the most common cancer in the world. The disease is common due to factors such as occupational exposure, smoking and environmental pollution. The early diagnosis and treatment of the disease is of great importance as well as the prevention of the causes that cause the disease.
arxiv